Thus, the particular susceptibility of the colon to insufficient vascular perfusion[1] mandates that the main focus of the treatment of such conditions should be bypassing one or more of the vascular obstructions
Lee MS, Overman MJ, Maru DM, Jiang Z, Manuel S, Eng C, Kee BK, Fogelman DR, Garrett CR, Advani SM, Sanchez EV, Shureiqi I, Wolff RA, Hamilton SR, Kopetz S
14 in The Lancet Diabetes & Endocrinology.The results suggest that a higher dose of semaglutide up to 7.2 mg per week could be used to achieve greater clinical benefits in people not reaching therapeutic goals with once-weekly semaglutide 2.4 mg, concluded a team led by Dr
It's always best to consult a healthcare professional before starting